Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ranibizumab plus selective peripheral laser for central retinal vein occlusion
2010-020441-27Phase 2Completed
- Sponsor
- Leipzig University
- Start
- Feb 2011
- Modality
- Antibody Fragments → Engineered Antibody Formats → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Phase 2, single-arm trial of ranibizumab in central retinal vein occlusion with macular edema and central retinal vein occlusion (CRVO), sponsored by Leipzig University. Primary endpoint: Best Corrected Visual Acuity (BCVA) of the study eye. Started Feb 2011; status: completed.
02
Drugs
ranibizumab
03
Conditions
central retinal vein occlusion with macular edemacentral retinal vein occlusion (CRVO)
Beyond the preview
Go deeper on 2010-020441-27.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-020441-27.